Biology of Blood and Marrow Transplantation
Volume 11, Issue 11 , Pages 881-889 , November 2005

Effect of Conditioning Regimen on the Outcome of Bone Marrow Transplantation from an Unrelated Donor

  • Yoshinobu Kanda

      Affiliations

    • Department of Cell Therapy & Transplantation Medicine, University of Tokyo, Tokyo, Japan
    • Corresponding Author InformationCorrespondence and reprint requests: Yoshinobu Kanda, MD, PhD, Department of Cell Therapy & Transplantation Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
    • ,
  • Hisashi Sakamaki

      Affiliations

    • Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    • ,
  • Hiroshi Sao

      Affiliations

    • Department of Hematology, Meitetsu Hospital, Aichi, Japan
    • ,
  • Shinichiro Okamoto

      Affiliations

    • Division of Hematology, Keio University School of Medicine, Tokyo, Japan
    • ,
  • Yoshihisa Kodera

      Affiliations

    • Japanese Red Cross Nagoya First Hospital, Aichi, Japan
    • ,
  • Ryuji Tanosaki

      Affiliations

    • National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Masaharu Kasai

      Affiliations

    • Sapporo Hokuyu Hospital, Hokkaido, Japan
    • ,
  • Akira Hiraoka

      Affiliations

    • Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
    • ,
  • Satoshi Takahashi

      Affiliations

    • Department of Hematology/Oncology, Institute of Medical Science, Tokyo, Japan
    • ,
  • Shuichi Miyawaki

      Affiliations

    • Saiseikai Maebashi Hospital, Gunma, Japan
    • ,
  • Takakazu Kawase

      Affiliations

    • Department of Cell Therapy, Aichi Cancer Center, Aichi, Japan
    • ,
  • Yasuo Morishima

      Affiliations

    • Department of Cell Therapy, Aichi Cancer Center, Aichi, Japan
    • ,
  • Shunichi Kato

      Affiliations

    • Department of Cell Transplantation & Regeneration Medicine, Tokai University School of Medicine, Kanagawa, Japan
    • ,
  • Japan Marrow Donor Program

Received 11 June 2005 ,Accepted 10 July 2005.

References 

  1. Fefer A , Einstein AB , Thomas ED , et al.   Bone-marrow transplantation for hematologic neoplasia in 16 patients with identical twins . N Engl J Med . 1974;290:1389–1393
  2. Thomas ED , Storb R , Clift RA , et al.   Bone-marrow transplantation (second of two parts) . N Engl J Med . 1975;292:895–902
  3. Tutschka PJ , Copelan EA , Klein JP . Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen . Blood . 1987;70:1382–1388
  4. Santos GW , Tutschka PJ , Brookmeyer R , et al.   Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide . N Engl J Med . 1983;309:1347–1353
  5. Blaise D , Maraninchi D , Archimbaud E , et al.   Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d’Etudes de la Greffe de Moelle Osseuse . Blood . 1992;79:2578–2582
  6. Clift RA , Buckner CD , Thomas ED , et al.   Marrow transplantation for chronic myeloid leukemia (a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide) . Blood . 1994;84:2036–2043
  7. Devergie A , Blaise D , Attal M , et al.   Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM) . Blood . 1995;85:2263–2268
  8. Ringden O , Ruutu T , Remberger M , et al.   A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia (a report from the Nordic Bone Marrow Transplantation Group) . Blood . 1994;83:2723–2730
  9. Hartman AR , Williams SF , Dillon JJ . Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation (a meta-analysis) . Bone Marrow Transplant . 1998;22:439–443
  10. Socié G , Clift RA , Blaise D , et al.   Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia (long-term follow-up of 4 randomized studies) . Blood . 2001;98:3569–3574
  11. Sahebi F , Copelan E , Crilley P , et al.   Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen . Bone Marrow Transplant . 1996;17:685–689
  12. Bertz H , Potthoff K , Mertelsmann R , Finke J . Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT (excellent feasibility and low incidence of treatment-related toxicity) . Bone Marrow Transplant . 1997;19:1169–1173
  13. Horning SJ , Chao NJ , Negrin RS , et al.   The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin’s disease and non-Hodgkin’s lymphoma (preliminary data) . Ann Oncol . 1991;2(suppl 1):47–50
  14. Riddell S , Appelbaum FR , Buckner CD , et al.   High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia . J Clin Oncol . 1988;6:576–582
  15. Kantarjian HM , Talpaz M , Andersson B , et al.   High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia . Bone Marrow Transplant . 1994;14:57–61
  16. Morishima Y , Sasazuki T , Inoko H , et al.   The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors . Blood . 2002;99:4200–4206
  17. Kodera Y , Morishima Y , Kato S , et al.   Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program (confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia) . Bone Marrow Transplant . 1999;24:995–1003
  18. Sasazuki T , Juji T , Morishima Y , et al.   Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program . N Engl J Med . 1998;339:1177–1185
  19. Glucksberg H , Storb R , Fefer A , et al.   Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors . Transplantation . 1974;18:295–304
  20. Gooley TA , Leisenring W , Crowley J , Storer BE . Estimation of failure probabilities in the presence of competing risks (new representations of old estimators) . Stat Med . 1999;18:695–706
  21. Kanda Y , Chiba S , Hirai H , et al.   Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000) . Blood . 2003;102:1541–1547
  22. Deeg HJ , Storer B , Slattery JT , et al.   Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome . Blood . 2002;100:1201–1207
  23. Matsuo K , Hamajima N , Morishima Y , Harada M . Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation (analysis of data from the Japan Society for Hematopoietic Cell Transplantation) . Bone Marrow Transplant . 2000;26:1061–1067
  24. Ringden O , Labopin M , Gorin NC , et al.   Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death (a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation) . J Clin Oncol . 2004;22:416–423
  25. Appelbaum FR . Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation (does haste make waste?) . J Clin Oncol . 2004;22:390–391

PII: S1083-8791(05)00429-5

doi: 10.1016/j.bbmt.2005.07.005

Biology of Blood and Marrow Transplantation
Volume 11, Issue 11 , Pages 881-889 , November 2005

Article Tools

* Image Usage & Resolution